🚀 VC round data is live in beta, check it out!
Level Bio Valuation Multiples
Discover revenue and EBITDA valuation multiples for Level Bio and similar public comparables like Lumito, Attana, Elite Diagnostic, Spermosens and more.
Level Bio Overview
About Level Bio
Level Bio AB is a parent company and operates through subsidiary. It develops and manufactures diagnostic kits for the clinical market and also is a distributor and full service partner to molecular biology labs in the Nordics.
Founded
1975
HQ
Employees
9
Website
Financials (FY)
EV
$2M
Level Bio Financials
Level Bio reported last fiscal year revenue of $4M and negative EBITDA of ($141K).
In the same fiscal year, Level Bio generated $2M in gross profit, ($141K) in EBITDA losses, and had net loss of ($386K).
Level Bio P&L
In the most recent fiscal year, Level Bio reported revenue of $4M and EBITDA of ($141K).
Level Bio expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $4M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $2M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 53% | XXX | XXX | XXX |
| EBITDA | — | XXX | ($141K) | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | (4%) | XXX | XXX | XXX |
| EBIT Margin | — | XXX | (11%) | XXX | XXX | XXX |
| Net Profit | — | XXX | ($386K) | XXX | XXX | XXX |
| Net Margin | — | XXX | (11%) | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Level Bio Stock Performance
Level Bio has current market cap of $2M, and enterprise value of $2M.
Market Cap Evolution
Level Bio's stock price is $0.03.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $2M | $2M | 0.3% | XXX | XXX | XXX | $-0.01 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialLevel Bio Valuation Multiples
Level Bio trades at 0.7x EV/Revenue multiple, and (16.8x) EV/EBITDA.
Level Bio Financial Valuation Multiples
As of April 20, 2026, Level Bio has market cap of $2M and EV of $2M.
Equity research analysts estimate Level Bio's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Level Bio has a P/E ratio of (6.1x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $2M | XXX | $2M | XXX | XXX | XXX |
| EV (current) | $2M | XXX | $2M | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 0.7x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | (16.8x) | XXX | XXX | XXX |
| EV/EBIT | — | XXX | (6.3x) | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 1.3x | XXX | XXX | XXX |
| P/E | — | XXX | (6.1x) | XXX | XXX | XXX |
| EV/FCF | — | XXX | 26.6x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Level Bio Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Level Bio Margins & Growth Rates
Level Bio's revenue in the last fiscal year grew by 29%.
Level Bio's revenue per employee in the last FY averaged $0.4M, while opex per employee averaged $0.2M for the same period.
Level Bio Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | 29% | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | (4%) | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | (78%) | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.4M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 63% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Level Bio Public Comps
See public comps and valuation multiples for other Medical Imaging & Diagnostics comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Level Bio | XXX | XXX | XXX | XXX | XXX | XXX |
| Lumito | XXX | XXX | XXX | XXX | XXX | XXX |
| Attana | XXX | XXX | XXX | XXX | XXX | XXX |
| Elite Diagnostic | XXX | XXX | XXX | XXX | XXX | XXX |
| Spermosens | XXX | XXX | XXX | XXX | XXX | XXX |
| NanoEcho | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Level Bio M&A Activity
Level Bio acquired XXX companies to date.
Last acquisition by Level Bio was on XXXXXXXX, XXXXX. Level Bio acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Level Bio
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialLevel Bio Investment Activity
Level Bio invested in XXX companies to date.
Level Bio made its latest investment on XXXXXXXX, XXXXX. Level Bio invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Level Bio
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Level Bio
| When was Level Bio founded? | Level Bio was founded in 1975. |
| Where is Level Bio headquartered? | Level Bio is headquartered in Sweden. |
| How many employees does Level Bio have? | As of today, Level Bio has over 9 employees. |
| Is Level Bio publicly listed? | Yes, Level Bio is a public company listed on Nasdaq Global Market. |
| What is the stock symbol of Level Bio? | Level Bio trades under LEVBIO ticker. |
| When did Level Bio go public? | Level Bio went public in 2024. |
| Who are competitors of Level Bio? | Level Bio main competitors are Lumito, Attana, Elite Diagnostic, Spermosens. |
| What is the current market cap of Level Bio? | Level Bio's current market cap is $2M. |
| What is the current revenue of Level Bio? | Level Bio's last fiscal year revenue is $4M. |
| What is the current EV/Revenue multiple of Level Bio? | Current revenue multiple of Level Bio is 0.7x. |
| Is Level Bio profitable? | No, Level Bio is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.